Skip to content
Vivo logo
← All articles

Who Prescribes Peptides in the U.S.? Your Location Sets the Rules

Who Prescribes Peptides in the U.S.? Your Location Sets the Rules

Abstract illustration of location-based care rules

Licensed physicians, MDs and DOs, hold the broadest legal authority to prescribe peptide therapies in the United States, and nurse practitioners and physician assistants can also prescribe within limits set by their state. The core constraint is not who you ask but what you request: FDA-approved peptides follow standard prescribing rules, while compounded peptides require a patient-specific prescription filled by a licensed 503A or 503B pharmacy, and telehealth prescribers must hold a license in the state where you are physically located at the time of your visit.

TL;DR:

  • Nurse practitioners and physician assistants may need a physician agreement, and every telehealth prescriber must be licensed where you are physically located.
  • A 503A pharmacy compounds for each prescription, while a 503B facility registered with the FDA can distribute larger batches; registration alone does not guarantee quality.
  • The FDA has approved semaglutide, tirzepatide, and bremelanotide, while BPC 157, CJC 1295, and TB 500 lack a legal pathway for human compounding.
  • Before prescribing through telehealth, clinicians should document medical history, allow discussion of alternatives, and arrange baseline testing when the therapy warrants it.
Vivo ClinicChoose Peptide Care With Medical OversightVivo Clinic offers provider-supervised therapies, personalized treatment selection, and precision-compounded treatments prepared by licensed U.S. pharmacies.Explore treatment options

Table of Contents

Which clinicians can legally write a peptide prescription?

Physicians carry the widest prescribing authority in the country. An MD or DO can prescribe FDA-approved peptides and, where permitted, compounded formulations, without the scope restrictions that apply to other licensed prescribers.

Nurse practitioners and physician assistants occupy a more variable position. Some states grant full practice authority, allowing independent prescribing once licensure requirements are met. Others fall into reduced or restricted practice categories, where a collaborative or supervisory agreement with a physician is required before certain prescriptions, including some peptide therapies, can be written. These agreements can affect which drug categories an NP or PA may prescribe independently, so the rules are not uniform from one state to the next.

Controlled substance registration adds another layer for any prescriber handling drugs with abuse potential, though most peptide therapies used for anti-aging and metabolic support do not fall into that category. Still, the underlying principle holds: scope of practice determines what a non-physician prescriber can legally offer, and that scope changes at the state line.

Before accepting a treatment plan, confirm a few things about your prescriber:

  • Check that the license is active in the state where you will be located during the consultation, not just where the clinic is headquartered.
  • Ask whether an NP or PA is operating under a collaborative agreement, and whether that agreement covers the therapy being discussed.
  • Confirm the credential type (MD, DO, NP, PA) directly through a state licensing lookup rather than relying on a clinic’s own description.

How pharmacies actually fill a peptide prescription

A prescription for a compounded peptide does not go to a standard retail pharmacy. It goes to a facility operating under one of two regulatory pathways defined in the FD&C Act: 503A or 503B.

A 503A pharmacy compounds on a patient-specific basis, meaning each preparation is tied to an individual prescription and the pharmacy operates under state board of pharmacy oversight. A 503B outsourcing facility is registered directly with the FDA and compounds in larger batches under current good manufacturing practice standards, which allows it to supply clinics and prescribers without a prescription attached to each individual unit before distribution.

Two distinct routes for compounded peptide preparation

One registration status determines everything downstream: whether a pharmacy is 503A or 503B registered dictates the oversight standard, batch testing expectations, and how traceable a given peptide vial actually is.

Before accepting a filled prescription, it is reasonable to ask:

  • Which pharmacy is filling this prescription, and is it registered as 503A or 503B?
  • Does the pharmacy hold Pharmacy Compounding Accreditation Board (PCAB) accreditation?
  • Can the pharmacy provide a certificate of analysis showing batch testing results for the specific peptide?

A closer look at how clinicians vet 503A and 503B shipments shows that registration status alone does not guarantee quality. It simply tells you which oversight framework applies.

Who typically manages peptide therapy by specialty?

Peptide prescribing tends to cluster around a handful of specialties, each tied to a specific clinical use case rather than peptides as a single category.

  • Endocrinology and internal medicine: manage GLP-1 therapies like semaglutide and tirzepatide for diabetes and weight management, often with the most established monitoring protocols.
  • Dermatology: prescribes topical peptide formulations aimed at skin structure and appearance.
  • Sports medicine and physical medicine and rehabilitation: use select peptides as part of recovery and healing protocols when clinically justified by the patient’s history.
  • Anti-aging and longevity clinics: build specialized compounded protocols, typically combining several peptide types, under ongoing medical supervision rather than a single prescription event.

The common thread across all four is that the peptide is tied to a documented clinical rationale, not requested as a standalone product.

Why your location, not your prescriber’s, decides who can treat you

Telehealth has made peptide consultations more accessible, but the legal rule has not changed: the practice of medicine occurs where the patient is physically located at the time of the visit. A prescriber must hold a license, or an approved telemedicine registration, in that state, according to state-by-state telemedicine policy data compiled by the Federation of State Medical Boards.

This creates real variation in access. Some states participate in licensure compacts or offer special telehealth registrations that simplify cross-state care. Others require a full, separate license before a prescriber can treat a resident at all, which means most telehealth prescribers are limited to a defined list of states where they hold authority.

A legitimate telehealth evaluation includes three elements before any prescription is written:

  1. A documented medical history and intake, not a one-page symptom checklist.
  2. An opportunity for you to ask follow-up questions and discuss alternatives with the prescriber.
  3. A plan for diagnostics, such as baseline labs, when the therapy warrants them.

Pro Tip: Ask any telehealth provider which states they are licensed or registered in before booking, so you are not surprised when a prescription cannot be written after the consultation.

How to verify a peptide prescriber and pharmacy before you commit

Verification takes a few minutes and it is worth doing before any payment or prescription is finalized.

  1. Look up the prescriber’s license status and specialty through your state’s medical, nursing, or physician assistant board website.
  2. Ask directly which pharmacy will fill the prescription, then confirm its 503A or 503B status, PCAB accreditation, and FDA registration if applicable.
  3. Request a certificate of analysis for the specific peptide and batch, not a generic quality statement.
  4. Confirm how the clinic handles follow-up labs, monitoring, and data privacy, including whether its intake process is HIPAA compliant.

A few questions separate a compliant clinic from one to avoid:

  • Can you name the compounding pharmacy you work with, and is it registered?
  • What does ongoing monitoring look like after the first prescription?
  • Is a documented consultation required before any prescription is written?

Pro Tip: Treat any offer of a peptide without a consultation, labeled only as a “research chemical,” as a red flag rather than a shortcut. A state pharmacy license lookup is worth more than a badge on a website, and a closer review of compounding standards from an industry partner outlines similar red flags clinicians are trained to watch for.

Which peptides can be prescribed and which stay research-only

The clearest dividing line runs between FDA-approved drugs and products with no legal prescribing pathway. Semaglutide, tirzepatide, and bremelanotide are FDA-approved and can also be compounded under specific conditions when permitted.

FDA’s Category 2 list affects which peptides a compounding pharmacy may legally prepare, and recent FDA guidance on compounded GLP-1 products has tightened the rules around semaglutide and tirzepatide specifically.

Peptides like BPC-157, CJC-1295, and TB-500, often marketed online as research chemicals, lack an approved pathway for human compounding, which means no legitimate prescriber can write a compliant prescription for them regardless of how they are advertised.

What a safe, supervised approach to peptide prescribing looks like

The regulatory patchwork around peptide prescribing puts the burden of verification on the patient, and that burden is exactly where our model starts. Our intake process is built around provider-supervised evaluation, meaning every treatment plan begins with a licensed clinician reviewing history and goals before any prescription is written.

Every compounded formulation is sourced through licensed U.S. compounding pharmacies, and patient data is handled under HIPAA-compliant practices throughout the consultation and fulfillment process. Our prescribing and fulfillment workflow reflects the same verification standards this guide recommends: confirmed licensure, documented evaluation, and pharmacy accountability, not a one-time questionnaire followed by a shipment.

— Jack

A path forward if you want supervised peptide therapy

If the verification steps above feel like a lot to manage on your own, that is precisely the gap our service is built to close. We pair you with a licensed prescriber for a documented telehealth consultation, then fill your prescription through a licensed U.S. compounding pharmacy, with ongoing provider oversight built into every plan.

  • Telehealth consultations with licensed prescribers before any prescription may be written.
  • Compounded formulations sourced from licensed U.S. pharmacies, including Sermorelin and Tirzepatide & Semaglutide.
  • Ongoing monitoring and HIPAA-compliant data handling throughout treatment.

Book a consultation through our Tirzepatide & Semaglutide program to see whether a supervised plan fits your goals.

This article is general information, not a substitute for advice from a licensed provider. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

What peptide does Pat McAfee take?

We have no verified, publicly documented record of a specific peptide regimen tied to this individual, and we do not speculate on any person’s private medical choices. Any peptide decision should come from a documented consultation with a licensed prescriber rather than a public figure’s reported routine.

What are the top 5 peptide companies?

There is no official, government-maintained ranking of peptide companies, so any such list reflects a particular publication’s criteria rather than a regulatory standard. Patients are better served comparing providers on licensure, pharmacy registration, and monitoring practices than on marketing rankings.

What is safer, TRT or peptides?

Neither category is inherently safer, since both depend on the specific compound, dose, and quality of medical supervision involved. The determining factors are an accurate diagnosis, a licensed prescriber’s documented evaluation, and sourcing through a properly registered compounding pharmacy.

How much do peptides cost to manufacture?

Manufacturing cost data for individual peptides is not publicly standardized, since it varies by compound, batch size, and the compounding facility’s processes. Patients typically see this reflected in the final prescription price rather than a separate manufacturing line item, and our overview of typical U.S. peptide therapy costs covers what that pricing usually includes.

Do doctors prescribe peptides without an in-person visit?

Yes, licensed physicians, NPs, and PAs can prescribe peptides through telehealth, provided the prescriber is licensed in the state where the patient is located and completes a documented evaluation. A valid telehealth visit still requires a real consultation, not a brief online form with no clinician review.

Sources

Authoritative resources to check before you choose a prescriber

A few primary sources let you verify any claim in this guide directly rather than taking a clinic’s word for it.